Trending >

Americans shouldn’t pay more for drugs than Canadians, says Bernie Sanders

Bernie Sanders

Bernie SandersBernie Sanders has clearly had it with American pharmaceutical companies gouging customers, and on Sunday he brought Canada into the debate.

In a tweet sent out Sunday morning, Sanders continued his attack on big pharma in a style that has endeared the 75 year-old Vermont Senator to millions.

“Americans shouldn’t pay higher prices than Canadians for the same drugs simply because Congress is bought by the pharmaceutical industry,” said Sanders.

Included with the tweet was a chart listing the various prices paid for drugs in the United States compared to their Canadian prices. The chart says Canadians pay $290 for an Epipen versus the U.S. price of $620, and $160 for cholesterol drug Crestor against $730 for the drug south of the border, for example.


This isn’t the first time Sanders has railed against pharmaceuticals companies, nor the first time he has taken to Twitter to do so.

“Drug corporations’ greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year,” he tweeted on October 14. That tweet, pointed out the Washington Post, sent shares of Ariad “tumbling”, as Sanders and Democratic Senator Elijah E. Cummings followed up with a letter to the company. Ariad responded by saying it had lost nearly $1.4-billion developing the drug.

Drug pricing scandals became an election issue more than a year ago when Martin Shkreli, the 32-year-old founder and CEO of Turing Pharmaceuticals bowed to public pressure and said the company would scrap plans to raise the price of Daraprim by more than 5,000%, from $13.50 to more than $750 per pill. Daraprim is a 63-year-old drug that is used to treat a life-threatening parasitic infection. The debate already had taken a Canadian turn, as earlier in 2015 after two members of the U.S. Congress who had been investigating generic drug price increases wrote to Canada’s Valeant Pharmaceuticals after it acquired two heart drugs, Isuprel and Nitropress, from Marathon Pharmaceuticals and then raised their prices. Shares of Valeant fell sharply last year and have not recovered.

On his website, Sanders lays out his case for changing the way drugs are priced in the United States.

“In any given month, more than half of all American adults take at least one prescription drug,” he said. “There is no question that medicines help millions of people live healthier and longer lives, and can also prevent more expensive illnesses and treatments. However, it is unacceptable that the United States now spends more than $370 billion on prescription drugs and spending is rising faster than at any point in the last decade. Instead of listening to the demands of the pharmaceutical industry and their 1,400 lobbyists, it is time that Congress started listening to the American people, who overwhelmingly believe that the cost of medication is too expensive. More than 70 percent of Americans believe drug costs are unreasonable and that drug companies are putting profits before people.”

The most recent large pharma scandal focused on the EpiPen, which is used to treat medical conditions such as anaphylaxis and cardiac arrest. It revealed the stark differences between the way drug pricing works in Canada and the United States.

EpiPen commands a virtual monopoly over the market in North America and is distributed in Canada by Pfizer. But its price has not risen in five years in Canada because drugs pricing here is controlled by a federal review board called the Patented Medicine Price Review Board.

“The regulatory pricing system here is different than in the U.S.,” says Laurie Harada, executive director for Food Allergy Canada, “and so we have not seen huge increases for the device year over year.”

Under Sanders plan, U.S. citizens would be able to import prescription drugs from Canada, but many aren’t waiting for that permission. Earlier this year, the Canadian International Pharmacy Association reported that dozens of the pharmacies it represents had seen an uptick in mail orders from the United States.

More Cantech Life Sciences

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
insta twitter facebook


  1. Know these pharma pricks they won’t give US citizens a break, rather they will just try to force the Canadian prices up. Shhhh We have a great single payer system here. Corps don’t tell our gov what to do, they still seem to serve us. Strange how your system is so up side down. To many ugly republicans I guess they are the ruin of the country. Trump will be the ruin of the country, he will be another G.Bush – maybe worse. At least G.Bush had Cheney and and daddy to keep is dogma in order.

Leave a Reply